ProSolus, Inc. delivers sophisticated transdermal solutions customized to meet your needs and exceed your expectations. We formulate, develop, and manufacture high-barrier-to-entry transdermal drug delivery products in our state-of-the-art laboratories and manufacturing facility. Our patches are designed with the patient in mind:

  • Non-irritating
  • Adherent: stays on the patient until he/she takes it off
  • Reliable: able to achieve reproducible blood levels
  • Small: as discreet as possible

ProSolus has the experience and flexibility to provide pilot, clinical supply, and commercial volumes, as well as support, under strict cGMP compliance:

  • Formulate, develop, and out-license TDDs in the U.S. and Internationally
  • Provide resources and technical support through commercialization
  • Execute agreements on a cost/profit sharing basis to commercialize TDDs
  • Offer fee-for-service development of TDDs identified by ProSolus
  • Collaborate with our partners to provide full or supplemental services to ensure speed to market